Vaccination And Immunization
- All
- News
- Videos
-
School-Based HPV Vaccination Programmes Reduce Risk Through Herd Immunity: Lancet Study
School-based immunisation against human papillomavirus (HPV) could also offer protection against the development of pre-cancerous cells in unvaccinated women through herd immunity.
-
US To Adopt Revised Childhood Immunization Schedule With Reduced Vaccines
The Centers for Disease Control and Prevention adopted a revised US childhood immunization schedule that reduces the number of vaccines recommended for all children.
-
World AMR Awareness Week 2025: The Role Of Vaccination In Reducing Antibiotic Resistance
One of the ways to prevent AMR is vaccination, which is often overlooked. Read on as Dr Neha Rastogi Panda explains the role of vaccines in reducing antimicrobial resistance.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
RFK Jr's Medical Panel To Review Contested Vaccine Claims
A vaccine panel appointed by US Health Secretary Robert F. Kennedy Jr. will revisit long-settled science and spotlight rare risks linked to childhood immunizations in a meeting beginning Wednesday
-
Experts Removed By Trump Health Chief "Deeply Concerned" Over His Vaccine Skepticism
Vaccination experts recently fired by Donald Trump's administration sounded the alarm in a Monday editorial, saying they were "deeply concerned" by the actions of a US health secretary known for his vaccine skepticism.
-
RFK Jr.s New Vaccine Panel Includes Self-Proclaimed Anti-Vaxxer
Health and Human Services Secretary Robert F. Kennedy Jr. announced eight new members of an expert panel that advises the federal government on immunization policy, including several vocal vaccine critics and one who identifies as an "anti-vaxxer."
-
Is There A Vaccine For HMPV: Tips For Staying Safe
Is There A Vaccine For HMPV: HMPV infection has no cure, the focus remains on understanding prevention, management, and treatment strategies to curb the virus's impact.
-
What Is A Tripledemic? Lookout For These Three Viruses That Cause Severe Respiratory Health Issues
India, with its vast population and diverse climatic conditions, faces the threat of a tripledemic during seasonal changes. Understanding these viruses and knowing how to prevent and treat them is crucial in staying healthy.
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
Cancer Prevention Through Vaccination: Understanding HPV and Hepatitis B Vaccine
Immunization is essential for preventing cancer, especially when it comes to Hepatitis B and the Human papillomavirus (HPV).
-
One-Shot Chikungunya Vaccine Found Safe, Effective In Phase 3 Trial: Study
A single-dose vaccine for chikungunya was found safe and produced a strong immune response against the viral disease, according to the first phase 3 trial of the preventive published in The Lancet journal.
-
School-Based HPV Vaccination Programmes Reduce Risk Through Herd Immunity: Lancet Study
School-based immunisation against human papillomavirus (HPV) could also offer protection against the development of pre-cancerous cells in unvaccinated women through herd immunity.
-
US To Adopt Revised Childhood Immunization Schedule With Reduced Vaccines
The Centers for Disease Control and Prevention adopted a revised US childhood immunization schedule that reduces the number of vaccines recommended for all children.
-
World AMR Awareness Week 2025: The Role Of Vaccination In Reducing Antibiotic Resistance
One of the ways to prevent AMR is vaccination, which is often overlooked. Read on as Dr Neha Rastogi Panda explains the role of vaccines in reducing antimicrobial resistance.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
RFK Jr's Medical Panel To Review Contested Vaccine Claims
A vaccine panel appointed by US Health Secretary Robert F. Kennedy Jr. will revisit long-settled science and spotlight rare risks linked to childhood immunizations in a meeting beginning Wednesday
-
Experts Removed By Trump Health Chief "Deeply Concerned" Over His Vaccine Skepticism
Vaccination experts recently fired by Donald Trump's administration sounded the alarm in a Monday editorial, saying they were "deeply concerned" by the actions of a US health secretary known for his vaccine skepticism.
-
RFK Jr.s New Vaccine Panel Includes Self-Proclaimed Anti-Vaxxer
Health and Human Services Secretary Robert F. Kennedy Jr. announced eight new members of an expert panel that advises the federal government on immunization policy, including several vocal vaccine critics and one who identifies as an "anti-vaxxer."
-
Is There A Vaccine For HMPV: Tips For Staying Safe
Is There A Vaccine For HMPV: HMPV infection has no cure, the focus remains on understanding prevention, management, and treatment strategies to curb the virus's impact.
-
What Is A Tripledemic? Lookout For These Three Viruses That Cause Severe Respiratory Health Issues
India, with its vast population and diverse climatic conditions, faces the threat of a tripledemic during seasonal changes. Understanding these viruses and knowing how to prevent and treat them is crucial in staying healthy.
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
Cancer Prevention Through Vaccination: Understanding HPV and Hepatitis B Vaccine
Immunization is essential for preventing cancer, especially when it comes to Hepatitis B and the Human papillomavirus (HPV).
-
One-Shot Chikungunya Vaccine Found Safe, Effective In Phase 3 Trial: Study
A single-dose vaccine for chikungunya was found safe and produced a strong immune response against the viral disease, according to the first phase 3 trial of the preventive published in The Lancet journal.
